NAYA Biosciences (NAYA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NAYA NAYA Biosciences

Watchlist

0.875
-0.025-2.77%

Close Nov 21 16:00 ET

0.875
0.000-0.01%

Post 18:09 ET

4.32MMarket Cap-866P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

NAYA Biosciences | 10-Q: Q3 2024 Earnings Report
SECNov 19 16:22 ET · Announcements
NAYA Biosciences | 10-Q/A: Quarterly report (Amendment)
SECNov 19 16:17 ET · Announcements
NAYA Biosciences | 10-K/A: Annual report (Amendment)
SECNov 19 16:13 ET · Announcements
Express News | Naya Biosciences Inc - Receives Approval to Initiate NY-303 Clinical Trial in Israel
ReutersOct 24 09:26 ET
Express News | Naya Biosciences Announces Initiation of Phase 1/2a Clinical Trial for Its Gpc3-Targeted Nk Engager Bispecific Antibody in Patients With Hepatocellular Carcinoma
ReutersOct 24 09:00 ET
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for Its GPC3-targeted NK Engager Bispecific Antibody in Patients With Hepatocellular Carcinoma
GlobeNewswireOct 24 09:00 ET

Comments

The Meganaire

Nov 19 16:17

$NAYA Biosciences (NAYA.US)$ good report naya thnx a lot

The Meganaire

Nov 14 13:45

rocket!!

$NAYA Biosciences (NAYA.US)$ it is going to go wild very soon, heeehaa! hope on before it is late! $1847 Holdings (EFSH.US)$ $Trump Media & Technology (DJT.US)$

72429422

Nov 14 13:40

$NAYA Biosciences (NAYA.US)$ buy at .79-.78, sell at .84-.85 every 2-3 days, rinse and repeat

The Meganaire

Nov 8 18:43

$NAYA Biosciences (NAYA.US)$ fuck good news NAYA is compliant to NasdaQ listing requirements.

Jaguar8

Oct 31 08:03

NEWS

$NAYA Biosciences (NAYA.US)$
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
SARASOTA, Fla. and MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today ...